H35.142 Retinopathy of prematurity, stage 3, left eye

Name of the Condition

• Retinopathy of prematurity, stage 3, left eye

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 3 represents a more advanced phase where abnormal blood vessels grow and partially detach the retina. This stage carries a higher risk of progression to severe vision loss if untreated, requiring prompt evaluation and intervention. The left eye is specifically affected in this diagnosis.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, with stage 3 reflecting significant retinal changes.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 3, ROP may not present obvious symptoms in infants. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the child grows. Infants with ROP are typically asymptomatic, and diagnosis relies on routine screening.

Diagnosis

Diagnosis is made through dilated eye examinations using indirect ophthalmoscopy, typically performed by a pediatric ophthalmologist. Screening guidelines recommend evaluations for premature infants based on gestational age and birth weight. Stage 3 is identified by the presence of extraretinal fibrovascular proliferation and partial retinal detachment.

Treatment Options

Treatment depends on the severity and progression of the condition. Options include:

• Laser therapy: Destroys abnormal blood vessels to prevent further growth.
• Cryotherapy: Freezes abnormal tissue to halt progression.
• Anti-VEGF injections: Blocks vascular endothelial growth factor to reduce abnormal vessel growth.
• Surgical intervention: May be required for advanced cases with retinal detachment.

Prognosis and Follow-Up

Prognosis varies based on the extent of retinal involvement and response to treatment. Early intervention improves outcomes, but some infants may still experience vision loss or require long-term monitoring. Follow-up care includes regular eye examinations to assess for recurrence or complications.

Complications

Potential complications include:

• Retinal detachment.
• Myopia (nearsightedness).
• Strabismus (crossed eyes).
• Amblyopia (lazy eye).
• Blindness in severe cases.

Lifestyle & Prevention

Prevention focuses on managing risk factors during neonatal care, such as careful oxygen administration and monitoring. For affected infants, lifelong vision monitoring and support services may be necessary.

When to Seek Professional Help

Seek immediate evaluation if an infant shows signs of eye abnormalities, such as leukocoria, abnormal eye movements, or if screening results indicate progression. Early intervention is critical to prevent vision loss.

Tips for Medical Coders

Document the specific eye (left) and stage (3) clearly in the medical record. Ensure the diagnosis is supported by clinical findings from dilated eye examinations. Code H35.142 is specific to stage 3 involvement of the left eye; verify laterality and stage details for accuracy.